Last reviewed · How we verify
NCT06581029
Evaluating Mental Health Challenges in Juvenile Lupus Erythematosus and Their Caregivers
trial testing The multidimensional peer victimization scale (PVS) in SLE in 62 participants. Not yet recruiting.
1 June 2026
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 62 |
| Start date | 1 June 2025 |
| Primary completion | 1 June 2026 |
| Estimated completion | 30 December 2026 |
Drugs / interventions tested
- The multidimensional peer victimization scale (PVS)
Conditions studied
- SLE — all drugs for SLE →
Sponsor
Assiut University
Who can join
Adults 11 to 18, any sex, with SLE. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
assessment of psychiatric problems in pediatric SLE and their caregivers. evaluate the possible risk factors of psychiatric problems such as peer victimization, academic performance, fatigue, self-esteem and quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06581029
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for SLE
Currently open trials in the same condition.
- NCT07203404 — A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. · EARLY_PHASE1 · recruiting
- NCT06839976 — CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus · Phase 1, PHASE2 · recruiting
- NCT06775912 — Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases · EARLY_PHASE1 · recruiting
- NCT07148115 — Pregnancies Before the Diagnosis of Systemic Lupus Erythematosus · recruiting
- NCT05822219 — Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases · NA · active not recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06581029 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 4 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06581029.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing